Zinc(II) phthalocyanine containing Schiff base containing sulfonamide: synthesis, characterization, photophysical, and photochemical properties

dc.authoridPiskin, Mehmet/0000-0002-4572-4905
dc.authoridCanpolat, Erdal/0000-0002-1167-0881
dc.contributor.authorSahal, Hakan
dc.contributor.authorPiskin, Mehmet
dc.contributor.authorOrgan, G. Atiye
dc.contributor.authorOzturk, O. Faruk
dc.contributor.authorKaya, Mehmet
dc.contributor.authorCanpolat, Erdal
dc.date.accessioned2025-01-27T20:45:27Z
dc.date.available2025-01-27T20:45:27Z
dc.date.issued2018
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractSynthesis and characterization of (E)-4-((5-bromo-2-(lambda(1)-oxidanyl)benzylidene)amino)-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide (1), its substituted phthalonitrile derivative (2), and its tetra substituted zinc(II) phthalocyanine complex (3) were performed. Compounds 1, 2, and 3 were characterized by methods such as elemental analyses, FT-IR, H-1-NMR, C-13-NMR (except for 3), and MALDI-TOF mass spectra. The photophysical and photochemical properties of this substituted zinc(II) phthalocyanine complex aimed to be used as a photosensitizer were investigated in DMSO solution for determination of their photosensitizing abilities in photocatalytic applications such as photodynamic therapy (PDT). The influence of the substituent as a bioactive compound on the phthalocyanine skeleton on spectroscopic, photophysical, and photochemical properties were also determined and compared with unsubstituted zinc(II) phthalocyanine and some zinc(II) phthalocyanines containing different substituents previously studied. According to photophysical and photochemical investigations, 3 has potential as a photosensitizer for PDT. [GRAPHICS] .
dc.description.sponsorshipCanakkale Onsekiz Mart University Scientific Research Projects Coordination Unit Project [FDK-2018-2567]
dc.description.sponsorshipCanakkale Onsekiz Mart University Scientific Research Projects Coordination Unit Project Code FDK-2018-2567.
dc.identifier.doi10.1080/00958972.2018.1524140
dc.identifier.endpage3775
dc.identifier.issn0095-8972
dc.identifier.issn1029-0389
dc.identifier.issue22
dc.identifier.scopus2-s2.0-85059042087
dc.identifier.scopusqualityQ3
dc.identifier.startpage3763
dc.identifier.urihttps://doi.org/10.1080/00958972.2018.1524140
dc.identifier.urihttps://hdl.handle.net/20.500.12428/24572
dc.identifier.volume71
dc.identifier.wosWOS:000461425800009
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofJournal of Coordination Chemistry
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectSulfa drug
dc.subjectSchiff base
dc.subjectbenzenesulfonamide
dc.subjectzinc(II) phthalocyanine
dc.subjectphotosensitizer
dc.titleZinc(II) phthalocyanine containing Schiff base containing sulfonamide: synthesis, characterization, photophysical, and photochemical properties
dc.typeArticle

Dosyalar